Jason Cleveland became SomaLogic Chief Technology Officer in 2021. He has more than 25 years of experience as a technology innovator in the area of scientific instruments. He joined SomaLogic as a consultant in 2015 and later became a principal research fellow in 2018. His work at SomaLogic has focused on near-term improvements to the SomaScan® Platform as well as technologies to miniaturize the SomaScan Assay to propel it towards patient-focused proteomics.
Prior to joining SomaLogic, Dr. Cleveland was the co-founder, chairman and later, Chief Executive Officer of Asylum Research in Santa Barbara, California, a manufacturer of atomic force microscopes founded in 1999 and sold to Oxford Instruments in 2012. As a hands-on CEO, he was heavily involved in the design of the Cypher AFM, which is still the quietest, fastest and most stable research atomic force microscope in the world with an installed base of more than 1,000 instruments. He began his career at Digital Instruments, which was the largest atomic force microscope company at the time.
Dr. Cleveland has a doctorate in physics from the University of California, Santa Barbara and bachelor’s degrees in math and physics from the University of Minnesota, Twin Cities where he was a Goldwater Scholar. He is a fellow of the American Physical Society and an author on over 40 scientific publications and an inventor on nearly 50 patents. He also serves as chairman of DE-CRUIT, a non-profit treating trauma in veterans through Shakespeare and science.